Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1480-1488. doi: 10.1002/pds.4866. Epub 2019 Aug 6.
People in residential aged care are at increased risk of adverse events from nonsteroidal anti-inflammatory drugs (NSAIDs) due to their age and health status, but little is known about use of NSAIDs in this setting. We aimed to estimate the prevalence of NSAID use by route, differences by high-risk conditions, prevalence of concurrent proton pump inhibitor (PPI) use, and prevalence of the "triple whammy" combination (oral NSAID, diuretic, and angiotensin-converting-enzyme inhibitor or angiotensin receptor antagonist).
We conducted a dynamic cohort study using medication administration data from 68 residential aged care facilities (RACFs) during 2014 to 2017. Descriptive statistics and regression were used to estimate the proportion of residents who used NSAIDs, NSAIDs long term, NSAIDs with PPIs, and the triple whammy combination.
Ten thousand three hundred sixty-seven residents were included. Two thousand four hundred fourteen (23.3%) used at least one NSAID: 756 (7.3%) used only oral, 1326 (12.8%) used only topical, and 332 (3.2%) used both topical and oral NSAIDs. One thousand five hundred forty two (14.8%) used an NSAID long term, a majority of which only used topical NSAIDs 933/1542 (60.5%). Age, sex, and health status were associated with greater variation in long-term topical use relative to oral NSAID use. A majority of oral NSAID users concomitantly used a PPI, which varied according to age, sex, and health status. Among residents with any oral NSAID use, 182/1088 (16.7%) had triple whammy medication use.
Targeted interventions to reduce NSAID use among RACF residents, to reduce triple whammy medication use, and increase PPI use for long-term oral NSAID users are warranted.
由于年龄和健康状况,居住在养老院的人因非甾体抗炎药(NSAIDs)而发生不良事件的风险增加,但人们对这一环境中 NSAIDs 的使用知之甚少。我们旨在通过途径估计 NSAIDs 的使用频率、高危疾病的差异、质子泵抑制剂(PPI)同时使用的频率以及“三重打击”组合(口服 NSAIDs、利尿剂和血管紧张素转换酶抑制剂或血管紧张素受体拮抗剂)的流行率。
我们使用 2014 年至 2017 年期间 68 家养老院的药物管理数据进行了一项动态队列研究。使用描述性统计和回归来估计使用 NSAIDs、长期 NSAIDs、与 PPI 联合使用的 NSAIDs 以及“三重打击”组合的居民比例。
共纳入 10367 名居民。2414 名(23.3%)至少使用了一种 NSAID:756 名(7.3%)仅使用口服,1326 名(12.8%)仅使用局部,332 名(3.2%)同时使用局部和口服 NSAIDs。1542 名(14.8%)长期使用 NSAIDs,其中大多数仅使用局部 NSAIDs 933/1542(60.5%)。年龄、性别和健康状况与长期局部使用相对于口服 NSAID 使用的差异更大。大多数口服 NSAID 用户同时使用 PPI,这取决于年龄、性别和健康状况。在有任何口服 NSAID 使用的居民中,182/1088(16.7%)有三重打击药物使用。
需要针对养老院居民减少 NSAIDs 的使用、减少三重打击药物的使用以及增加长期口服 NSAIDs 使用者的 PPI 使用进行有针对性的干预。